Eva Idén

Member of the Board of Directors

Finansinspektionen (Sweden) Files from Sweden

Compiled from cited public records — every figure names the disclosure it came from, none copied from any wealth ranking. How we calculate this.

Positions on file
1
positions reconstructed from transactions reported to Finansinspektionen (FI) in Sweden

Not measurable for this profile: Reconstructed positions · 1-day change

Trading activity May 10, 2024 – May 10, 2024

Eva Idén reported 1 transaction between May 10, 2024 and May 10, 2024. The buy and sell totals below count only code SACQ.

Open-market buys (SACQ)
18.0K SEK
1 purchase on file priced rows only
Open-market sales
None
0 sales on file
All reported transactions
1
every code, including awards and exercises
Pattern
No transaction in the final 12 months of the window
last 12 months of the window

Events from filings

Detected automatically in the filings linked below. Each headline is built from the numbers in those filings, not written by a model. Newest first; events older than 45 days stay listed and are marked as older.

4 insiders bought Infant Bacterial Therapeutics AB shares worth 374,633 SEK between May 10, 2024 and May 28, 2024

Cluster buying

4 different insiders made 12 open-market purchases of this company’s shares within a short window. Each row below is one reported trade. At least one price in this event could not be cross-checked against other trades in the same security, so read the total with extra care.

4 insiders bought Infant Bacterial Therapeutics AB shares worth 374,633 SEK between May 10, 2024 and May 28, 2024
Date Insider Transaction Shares Price Value Filing
May 10, 2024 Eva Idén SACQ Acquisition 200 89.80 SEK 17,960 SEK FI filing ↗
May 10, 2024 Anthon Jahreskog SACQ Acquisition 1,250 90.00 SEK 112,500 SEK FI filing ↗
May 10, 2024 Anthon Jahreskog SACQ Acquisition 178 89.00 SEK 15,842 SEK FI filing ↗
May 10, 2024 Anthon Jahreskog SACQ Acquisition 128 90.00 SEK 11,520 SEK FI filing ↗
May 10, 2024 Anthon Jahreskog SACQ Acquisition 894 92.00 SEK 82,248 SEK FI filing ↗
May 13, 2024 Margareta Hagman SACQ Acquisition 1,000 93.41 SEK 93,410 SEK FI filing ↗
May 17, 2024 Anthon Jahreskog SACQ Acquisition 37 96.20 SEK 3,559 SEK FI filing ↗
May 17, 2024 Anthon Jahreskog SACQ Acquisition 88 96.80 SEK 8,518 SEK FI filing ↗
May 17, 2024 Anthon Jahreskog SACQ Acquisition 56 97.20 SEK 5,443 SEK FI filing ↗
May 17, 2024 Anthon Jahreskog SACQ Acquisition 89 97.60 SEK 8,686 SEK FI filing ↗
May 28, 2024 Maria Ekdahl SACQ Acquisition 4 96.00 SEK 384 SEK FI filing ↗
May 28, 2024 Maria Ekdahl SACQ Acquisition 152 95.80 SEK 14,562 SEK FI filing ↗

Total of the rows above: 374,633 SEK, in the currency the filings report.

Source: Finansinspektionen (Sweden); every row links to where it was published. Event computed Sep 14, 2026.

Reported transactions

Price 0.00 is a real reported figure on allotments, gifts and option exercises — not a missing number. The 1 most recent row are grouped into 1 line by date, company and transaction type — open a line to see every lot with its own source link.

How to read this list

Every row is one insider transaction as reported to FI, with a link back to the FI register filtered to that issuer and publication date. FI publishes no per-report permalink, so the link is a search, not a document. Where the record carries no price at all we leave the cell empty instead of guessing one.

The shares and money on a grouped line add up only the lots listed inside that line, and only when every one of them carries the figure. Where a group mixes more than one reporting currency we leave the money blank rather than convert — no source publishes the rate that conversion would need.

  1. Infant Bacterial Therapeutics AB SACQ Acquisition 200 shares 18.0K SEK at 89.80 SEK FI filing ↗

Reconstructed positions

Reconstructed by adding up every transaction this person reported to FI since 2016. FI publishes transactions, not balances, so this is a computed figure, not a disclosed one — and it omits anything held before the register began.

What is not counted here

Each row comes from a public disclosure named on this page. Private companies, real estate, bonds and crypto are not in those disclosures and are therefore not counted here. Shares held through a holding company are recorded against that company, not against the individual behind it.

Equity positions reported to Finansinspektionen (FI) in Sweden, with the disclosure date shown on each row.
Issuer ISIN Security Shares Price Value Form Reported Filing
Infant Bacterial Therapeutics AB SE0008015259 Infant Bacterial Therapeutics AB ser. B 200 — — FI marknadssok.fi.se ↗

Other shareholders on record at the same companies

People who also appear on the shareholder record of a company where Eva Idén reports shares.

Sharing a filing does not mean they work together day to day — it means both names appear on the same issuer’s insider record.

Sources

Every figure on this page is quoted from the public record named beside it, with the date it was true. Nothing here is our own calculation.

Think a number here is wrong? Check the named disclosure and its date against the tables above — how to report it.

Profile record last refreshed Sep 14, 2026.